Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd312029d8k.htm
EX-99.1 - PRESS RELEASE OF AMERICAN VANGUARD CORPORATION-RE: PASSING OF JOHN B. MILES - AMERICAN VANGUARD CORPd312029dex991.htm

Exhibit 99.2

 

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS FOURTH QUARTER & FULL YEAR 2011 RESULTS

American Vanguard Doubles Profits on 34% Increase in Sales

Record-setting Performance — Continuing Strong Demand Anticipated

Newport Beach, CA – March 6, 2012 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the fourth quarter and full year ended December 31, 2011.

Fiscal 2011 Fourth Quarter– versus Fiscal 2010 Fourth Quarter:

 

   

Net sales were $84.7 million compared to $62.4 million, an increase of 36%.

 

   

Net income was $6.4 million compared to $3.9 million, an increase of 64%.

 

   

Earnings per diluted share were $0.23 versus $0.14.

Fiscal Full Year 2011– versus Fiscal Full Year 2010:

 

   

Net sales were $304.4 million compared to $226.9 million, an increase of 34%.

 

   

Net income was $22.1 million compared to $11.0 million, an increase of 101%.

 

   

Earnings per diluted share were $0.79 versus $0.40.

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “Our record-setting performance in 2011 resulted from strong domestic and international demand for our existing product portfolio, the successful integration of several product lines acquired in late 2010 and the continued outstanding business execution by our entire organization. Compared to the prior full-year period, sales grew by 34%, gross profit margin improved to 40%, operating expenses as a percentage of sales declined to 28%; allowing us to double our net income. We posted this record financial performance despite lost sales and profit opportunities caused by the year-long sales interruption of our PCNB product line, a supply shortage for one of our recently acquired products and a persistent drought that negatively affected our U.S. cotton insecticide business.”

Mr. Wintemute continued: “In 2012, we see many encouraging prospects. Ever-increasing global demand for food, feed, fiber and bio-fuels strengthens agricultural commodity prices and is expected to encourage growers to expand acreage and purchase the crop protection inputs that American Vanguard sells. Our Impact herbicide for glyphosate tolerant weeds, our industry leading granular soil insecticides and proprietary closed delivery systems will continue to provide a superior yield enhancing solution for our customers.”


Mr. Wintemute concluded: “American Vanguard is well positioned to capitalize on these trends. We anticipate steady growth in most of our domestic crop markets; we expect to expand our footprint in international markets and continue our penetration of the non-crop pest control segment. Our strong balance sheet will allow us to invest in these growth initiatives and increasing cash generation should allow us to provide enhanced near-term returns to shareholders and also consider available growth opportunities that will strengthen the long-term enterprise value of American Vanguard.”

Conference Call

Eric Wintemute, Chairman & CEO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 12:00 pm ET / 9:00 am PT on Tuesday, March 6, 2012. Interested parties may participate in the call by dialing (201) 493-6744 please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

Company Contact:         Investor Representative
American Vanguard Corporation       The Equity Group Inc.
William A. Kuser, Director of Investor Relations       www.theequitygroup.com
(949) 260-1200       Lena Cati
williamk@amvac-chemical.com       Lcati@equityny.com
      (212) 836-9611


CONSOLIDATED STATEMENTS OF OPERATIONS

Three months and twelve months ended December 31, 2011 and 2010

(Dollars in thousands, except per share data)

 

     For the three months
ended December 31
    For the twelve months
ended December 31
 
     2011     2010     2011     2010  

Net sales

   $ 84,680      $ 62,413      $ 304,429      $ 226,859   

Cost of sales

     50,768        36,931        181,361        140,538   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     33,912        25,482        123,068        86,321   

Operating expenses

     22,724        20,044        83,842        67,130   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     11,188        5,438        39,226        19,191   

Interest expense

     882        691        3,569        3,171   

Interest income

     —          —          (3     —     

Interest capitalized

     (17     (56     (109     (154

Extinguishment of debt

     —          —          546        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income tax

     10,323        4,803        35,223        16,174   

Income tax expense

     3,892        900        13,155        5,190   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 6,431      $ 3,903      $ 22,068      $ 10,984   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—basic

   $ .23      $ .14      $ .80      $ .40   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ .23      $ .14      $ .79      $ .40   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—basic

     27,583        27,452        27,559        27,385   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     28,026        27,682        27,875        27,652   
  

 

 

   

 

 

   

 

 

   

 

 

 


CONSOLIDATED BALANCE SHEETS

December 31, 2011 and 2010

(Dollars in thousands, except per share data)

 

     2011     2010  
Assets     

Current assets:

    

Cash

   $ 35,085      $ 1,158   

Receivables:

    

Trade, net of allowance for doubtful accounts of $340 and $447, respectively

     68,611        33,833   

Other

     1,187        263   
  

 

 

   

 

 

 
     69,798        34,096   
  

 

 

   

 

 

 

Inventories

     71,068        74,054   

Prepaid expenses

     2,311        2,591   

Income taxes receivable

     203        6,715   
  

 

 

   

 

 

 

Total current assets

     178,465        118,614   

Property, plant and equipment, net

     39,273        40,541   

Intangible assets, net

     116,189        115,249   

Other assets

     5,214        5,775   
  

 

 

   

 

 

 
   $ 339,141      $ 280,179   
  

 

 

   

 

 

 
Liabilities and Stockholders’ Equity     

Current liabilities:

    

Current installments of long-term debt

   $ 14,460      $ 8,429   

Current installments of other liabilities

     1,038        —     

Accounts payable

     23,214        13,961   

Deferred revenue

     7,571        5,568   

Accrued program costs

     25,910        16,976   

Accrued expenses and other payables

     6,832        4,634   
  

 

 

   

 

 

 

Total current liabilities

     79,025        49,568   

Long-term debt, excluding current installments

     51,917        53,710   

Other liabilities, excluding current installments

     5,955        3   

Deferred income taxes

     15,172        10,461   
  

 

 

   

 

 

 

Total liabilities

     152,069        113,742   
  

 

 

   

 

 

 

Commitments and contingent liabilities:

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —          —     

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 29,845,047 shares in 2011 and 29,735,928 shares in 2010

     2,985        2,974   

Additional paid-in capital

     45,966        43,403   

Accumulated other comprehensive loss

     (2,250     (448

Retained earnings

     143,524        123,661   
  

 

 

   

 

 

 
     190,225        169,590   

Less treasury stock at cost, 2,260,996 shares in both 2011 and 2010

     (3,153     (3,153
  

 

 

   

 

 

 

Total stockholders’ equity

     187,072        166,437   
  

 

 

   

 

 

 
   $ 339,141      $ 280,179   
  

 

 

   

 

 

 

See summary of significant accounting policies and notes to consolidated financial statements.


CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2011, 2010 and 2009

(Dollars in thousands, except per share data)

 

     2011     2010     2009  

Increase (decrease) in cash

      

Cash flows from operating activities:

      

Net income (loss)

   $ 22,068      $ 10,984      $ (5,789

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

      

Depreciation and amortization of fixed and intangible assets

     13,546        11,123        10,804   

Amortization of other long term assets

     1,983        3,258        2,683   

Amortization of discounted liabilities

     1,371        —          —     

Stock-based compensation

     1,994        1,122        1,223   

Increase(decrease) in deferred income taxes

     4,711        5,342        (778

Changes in assets and liabilities associated with operations:

      

(Increase) decrease in net receivables

     (35,021     6,967        10,905   

Decrease (increase) in inventories

     2,986        (1,542     18,114   

Decrease (increase) in income tax receivable

     6,512        (2,583     (4,132

(Increase) in prepaid expenses and other assets

     (1,823     (2,235     (2,898

Increase (decrease) in accounts payable

     8,383        3,095        (2,828

Increase in deferred revenue

     2,003        5,568        —     

Increase (decrease) in other payables and accrued expenses

     10,553        (7,909     4,647   
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     39,266        33,190        31,951   
  

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

      

Capital expenditures

     (6,261     (8,004     (4,322

Acquisitions of intangible assets

     (316     (32,677     —     
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (6,577     (40,681     (4,322
  

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

      

Net (repayments) borrowings under line of credit agreement

     (7,300     4,700        (21,900

Payments on long-term debt

     (8,429     (8,107     (4,106

Payment on other long-term liabilities

     (401     —          —     

Increase (decrease) in other notes payable

     20,063        11,586        (2,438

Proceeds from the issuance of common stock

     580        768        1,470   

Payment of cash dividends

     (2,205     (819     (1,611
  

 

 

   

 

 

   

 

 

 

Net cash provided (used in) by financing activities

     2,308        8,128        (28,585
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash

     34,997        637        (956

Effect of exchange rate changes on cash

     (1,070     138        110   

Cash at beginning of year

     1,158        383        1,229   
  

 

 

   

 

 

   

 

 

 

Cash at end of year

   $ 35,085      $ 1,158      $ 383   
  

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

      

Cash paid during the year for:

      

Interest

   $ 2,055      $ 3,661      $ 3,279   
  

 

 

   

 

 

   

 

 

 

Income taxes

   $ 6,359      $ 2,205      $ 3,361